Knowing what we do and doing what we should: quality assurance in hemodialysis.

Nephron Clinical Practice Pub Date : 2014-01-01 Epub Date: 2014-04-15 DOI:10.1159/000361050
Maria Alquist, Juan P Bosch, Claudia Barth, Christian Combe, John T Daugirdas, Jörgen B A Hegbrant, Georges Martin, Christopher W McIntyre, Donal J O'Donoghue, Hector J Rodriguez, Antonio Santoro, James E Tattersall, Georges Vantard, David B Van Wyck, Bernard Canaud
{"title":"Knowing what we do and doing what we should: quality assurance in hemodialysis.","authors":"Maria Alquist,&nbsp;Juan P Bosch,&nbsp;Claudia Barth,&nbsp;Christian Combe,&nbsp;John T Daugirdas,&nbsp;Jörgen B A Hegbrant,&nbsp;Georges Martin,&nbsp;Christopher W McIntyre,&nbsp;Donal J O'Donoghue,&nbsp;Hector J Rodriguez,&nbsp;Antonio Santoro,&nbsp;James E Tattersall,&nbsp;Georges Vantard,&nbsp;David B Van Wyck,&nbsp;Bernard Canaud","doi":"10.1159/000361050","DOIUrl":null,"url":null,"abstract":"<p><p>An international group of around 50 nephrologists and scientists, including representatives from large dialysis provider organisations, formulated recommendations on how to develop and implement quality assurance measures to improve individual hemodialysis patient care, population health and cost effectiveness. Discussed were methods thought to be of highest priority, those clinical indicators which might be most related to meaningful patient outcomes, tools to control treatment delivery and the role of facilitating computerized expert systems. Emphasis was given to the use of new technologies such as measurement of online dialysance and ways of assessing fluid status. The current evidence linking achievement of quality criteria with patient outcomes was reviewed. This paper summarizes useful processes and quality measures supporting quality assurance that have been agreed across the expert panel. It also notes areas where more understanding is required.</p>","PeriodicalId":19094,"journal":{"name":"Nephron Clinical Practice","volume":"126 3","pages":"135-43"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000361050","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephron Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000361050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/4/15 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11

Abstract

An international group of around 50 nephrologists and scientists, including representatives from large dialysis provider organisations, formulated recommendations on how to develop and implement quality assurance measures to improve individual hemodialysis patient care, population health and cost effectiveness. Discussed were methods thought to be of highest priority, those clinical indicators which might be most related to meaningful patient outcomes, tools to control treatment delivery and the role of facilitating computerized expert systems. Emphasis was given to the use of new technologies such as measurement of online dialysance and ways of assessing fluid status. The current evidence linking achievement of quality criteria with patient outcomes was reviewed. This paper summarizes useful processes and quality measures supporting quality assurance that have been agreed across the expert panel. It also notes areas where more understanding is required.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
知己知己:血液透析的质量保证。
一个由大约50名肾病学家和科学家组成的国际小组,包括来自大型透析提供者组织的代表,就如何制定和实施质量保证措施以改善个体血液透析患者护理、人口健康和成本效益制定了建议。讨论了被认为是最优先的方法,那些可能与有意义的患者结果最相关的临床指标,控制治疗交付的工具以及促进计算机专家系统的作用。重点是使用在线透析测量等新技术和评估流体状态的方法。目前的证据将质量标准的实现与患者的预后联系起来。本文总结了支持质量保证的有用过程和质量措施,这些过程和质量措施已在专家组中得到一致同意。它还指出了需要更多理解的领域。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Nephron Clinical Practice
Nephron Clinical Practice 医学-泌尿学与肾脏学
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
期刊最新文献
Comparison of Outcomes of In-Centre Haemodialysis Patients between the 1st and 2nd COVID-19 Outbreak in England, Wales, and Northern Ireland: A UK Renal Registry Analysis Association of Serum Triglycerides and Renal Outcomes among 1.6 Million US Veterans Genetic Deletion of the Stromal Cell Marker CD248 (Endosialin) Protects against the Development of Renal Fibrosis Contents Vol. 128, 2014 Author Index Vol. 127, No. 1-4, 2014
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1